TELA Bio (TELA) has priced its initial public offering of 4M shares of common stock at $13/share, for gross proceeds of $52M.
Underwriters over-allotment is an additional 600K shares of common stock.
The shares are expected to begin trading today on The Nasdaq Global Market.
The offering is expected to close on November 13.
Previously: TELA Bio sets IPO terms (Oct. 29)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.